<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587143</url>
  </required_header>
  <id_info>
    <org_study_id>GASOHUB</org_study_id>
    <nct_id>NCT02587143</nct_id>
  </id_info>
  <brief_title>Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures</brief_title>
  <official_title>Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bionorte</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Osakidetza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Basque Country University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bionorte</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ethyl chloride vapocoolant sprays provide transient skin anesthesia within seconds of
      application. The current investigation aim is to compare the effect of ethyl chloride based
      vapocoolant spray to placebo in reducing pain associated with arterial puncture for gasometry
      determinations.

      The investigators will conduce a double-blind randomized placebo-controlled trial at
      Emergency Department.

      We will enroll patients who come to Emergency Department who need an arterial gasometry
      determination. Patients will be randomized to intervention-group (ethyl chloride vapocoolant
      sprays will be usad before arterial puncture) or to placebo-group (alcohol spray as placebo
      will be used before arterial puncture.) and after the puncture they will rate their pain
      using a 10 points visual analogue scale.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Single-blind, randomized placebo-controlled trial in an emergency department of Hospital de
      Basurto in Bilbao, Spain. Patients for whom arterial blood gas analysis had been ordered will
      be included. They will be randomly assigned to receive application of the experimental ethyl
      chloride spray or a placebo aerosol spray of a solution of alcohol in water. The assigned
      spray will be applied just before arterial puncture. The main outcome variable is pain
      intensity reported on an 11-point numeric rating scale.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Level on the Visual Analog Scale (NRS-11)</measure>
    <time_frame>scores on a scale immediately after the puncture</time_frame>
    <description>patients will measure their pain score on a visual analog scale (NRS-11: Numeric Rate Score, from 0 -no pain- to 10 points -the worst pain ever-) after the puncture</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">126</enrollment>
  <condition>Anesthesia</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alcohol -based spray as placebo will be administrated before arterial puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ethyl chloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ethyl choride will be administrated before arterial puncture.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ethyl chloride</intervention_name>
    <description>Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture (of cubital arteria).</description>
    <arm_group_label>Ethyl chloride</arm_group_label>
    <other_name>Intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alcohol</intervention_name>
    <description>Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture (of cubital arteria).</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18-85 years old.

          -  arterial gasometry determination needed

          -  III, IV or V level classification on Manchester triage.

        Exclusion criteria:

          -  refusal to participate,

          -  inability to provide informed consent (non-Spanish speaking, dementia or altered
             mental state),

          -  skin disease associated with cold intolerance (Raynaud's phenomenon),

          -  known allergy to spray contents,

          -  Glasgow Coma Scale &lt;15,

          -  pregnancy,

          -  under effects of alcohol or drugs,

          -  Allen test +.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SENDOA BALLESTEROS-PEÑA, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HOSPITAL OF BASURTO (BILBAO)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital de Basurto</name>
      <address>
        <city>Bilbao</city>
        <state>Bizkaia</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Ballesteros-Peña S, Fernández-Aedo I, Vallejo-De la Hoz G; en representación del Grupo de Trabajo DIASURE. [Ethyl chloride aerosol spray for local anesthesia before arterial puncture: randomized placebo-controlled trial]. Emergencias. 2017 Jun;29(3):161-166. Spanish.</citation>
    <PMID>28825235</PMID>
  </results_reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 9, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <results_first_submitted>August 7, 2017</results_first_submitted>
  <results_first_submitted_qc>January 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 22, 2020</results_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bionorte</investigator_affiliation>
    <investigator_full_name>SENDOA BALLESTEROS-PEÑA</investigator_full_name>
    <investigator_title>Emergency nurse practitioner, PhD doctor.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethyl Chloride</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Seccondary effcts happens after punctre (dizziness...)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Ethyl Chloride</title>
          <description>Ethyl choride will be administrated before arterial puncture.
Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture.</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Alcohol -based spray as placebo will be administrated before arterial puncture.
Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>Alcohol -based spray as placebo will be administrated before arterial puncture.
Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture.</description>
        </group>
        <group group_id="B2">
          <title>Ethyl Chloride</title>
          <description>Ethyl choride will be administrated before arterial puncture.
Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
            <count group_id="B2" value="66"/>
            <count group_id="B3" value="126"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.7" spread="12.1"/>
                    <measurement group_id="B2" value="67.1" spread="14.4"/>
                    <measurement group_id="B3" value="67.9" spread="13.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Arteria of puncture</title>
          <description>Puncture on humeral arteria or cubital arteria</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Cubital arteria</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="106"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Humeral arteria</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Level on the Visual Analog Scale (NRS-11)</title>
        <description>patients will measure their pain score on a visual analog scale (NRS-11: Numeric Rate Score, from 0 -no pain- to 10 points -the worst pain ever-) after the puncture</description>
        <time_frame>scores on a scale immediately after the puncture</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>Alcohol -based spray as placebo will be administrated before arterial puncture.
Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture.</description>
          </group>
          <group group_id="O2">
            <title>Ethyl Chloride</title>
            <description>Ethyl choride will be administrated before arterial puncture.
Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture.</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Level on the Visual Analog Scale (NRS-11)</title>
          <description>patients will measure their pain score on a visual analog scale (NRS-11: Numeric Rate Score, from 0 -no pain- to 10 points -the worst pain ever-) after the puncture</description>
          <units>scores on scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="1" upper_limit="4.5"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Alcohol -based spray as placebo will be administrated before arterial puncture.
Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture (of cubital arteria).</description>
        </group>
        <group group_id="E2">
          <title>Ethyl Chloride</title>
          <description>Ethyl choride will be administrated before arterial puncture.
Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture (of cubital arteria).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness after puncture</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Local injury (ischaemia)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="66"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ballesteros-Peña</name_or_title>
      <organization>Servicio de Urgencias, Hospital de Basurto, Bilbao, España</organization>
      <phone>(+34)946012804</phone>
      <email>sendoa.ballesteros@ehu.eus</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

